NRIX - CIK 0001549595
Nurix Therapeutics, Inc. trades as NRIX and has a market capitalization of $1.85 B, making it the #2152 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $83.98M, up 54.0% from the prior year and net income of -$264.46M. This page tracks Nurix Therapeutics, Inc. through 511 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 6 fiscal years Nurix Therapeutics, Inc.'s revenue grew from $31.11M to $83.98M, a compound annual growth rate of 18.0%. Net profit margin compressed from -69.7% to -314.9% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Major company event | 8-K | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
Nurix Therapeutics to Participate in Upcoming Investor Conferences | Nurix Therapeutics, Inc.
Nurix Therapeutics Announces Bexobrutideg Oral Presentation at the 2026 European Hematology Association Congress | Nurix Therapeutics, Inc.
Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026 | Nurix Therapeutics, Inc.
Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update | Nurix Therapeutics, Inc.
Nurix Therapeutics to Participate in Upcoming Investor Conference | Nurix Therapeutics, Inc.
The largest companies sharing Nurix Therapeutics, Inc.'s SEC industry classification (pharmaceutical preparations).
Nurix Therapeutics, Inc. (NRIX) has a market capitalization of $1.85 B as of 2026-05-29, ranking #2152 among US-listed companies.
Nurix Therapeutics, Inc. reported revenue of $83.98M for fiscal year 2025, an increase of 54.0% year over year.
In its latest fiscal year Nurix Therapeutics, Inc. reported a net loss of $264.46M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.